Abstract
Angioendotheliomatosis proliferans systematisata comprises two different entities; a malignant and benign (reactive) form. The more common malignant form with a fatal prognosis should be termed intravascular or angiotropic lymphoma and is a multifocal systemic disease, which affects especially the small and middle-sized blood vessels of the skin and central nervous system. Reactive angioendotheliomatosis is a benign disease, often associated with an infectious disease (predominantly with subacute bacterial endocarditis). We report a 38-year-old woman with a reactive angioendotheliomatosis and a 68-year-old man diagnosed as having the rare T-cell type of intravascular lymphoma.
Publication types
-
Case Reports
-
Comparative Study
-
English Abstract
MeSH terms
-
Adult
-
Aged
-
Anti-Infective Agents / administration & dosage
-
Anti-Infective Agents / therapeutic use
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / therapeutic use
-
Antibodies, Antineutrophil Cytoplasmic / analysis
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Agents, Hormonal / administration & dosage
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Ciprofloxacin / administration & dosage
-
Ciprofloxacin / therapeutic use
-
Diagnosis, Differential
-
Female
-
Humans
-
Interferon-alpha / administration & dosage
-
Interferon-alpha / therapeutic use
-
Lymphoma, Non-Hodgkin* / diagnosis
-
Lymphoma, Non-Hodgkin* / drug therapy
-
Lymphoma, Non-Hodgkin* / pathology
-
Lymphoma, T-Cell* / diagnosis
-
Lymphoma, T-Cell* / drug therapy
-
Lymphoma, T-Cell* / pathology
-
Male
-
Prednisolone / administration & dosage
-
Prednisolone / therapeutic use
-
Skin / pathology
-
Skin Neoplasms* / pathology
-
Terminology as Topic
Substances
-
Anti-Infective Agents
-
Anti-Inflammatory Agents
-
Antibodies, Antineutrophil Cytoplasmic
-
Antineoplastic Agents
-
Antineoplastic Agents, Hormonal
-
Interferon-alpha
-
Ciprofloxacin
-
Prednisolone